BIFIDOBACTERIUM BREVE HA-129
UNII 8E7G9AK3ET

Substance Identification & Data

This profile provides standardized clinical and technical data for Bifidobacterium Breve Ha-129, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8E7G9AK3ET.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
8E7G9AK3ET
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BIFIDOBACTERIUM BREVE HA-129
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bifidobacterium Breve Ha-129. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

B. BREVE HA-129
BIFIDOBACTERIUM BREVE HA-129
ULTIMATE FLORA BABY PROBIOTIC (RENEW LIFE, PALM HARBOR, FL, USA) COMPONENT BIFIDOBACTERIUM BREVE HA-129

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record